- Allison, D.B., Mentore, J.L., Heo, M., Chandler, L.P., Cappelleri, J.C., Infante, M.C. & Weiden, P. (1999). Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry, 156, 1686-1696.
- Bentall, R.P. (1990). The syndromes and symptoms of psychosis: Or why you can't play 20 questions with the concept of schizophrenia and hope to win. In R.P. Bentall (Ed.), Reconstructing Schizophrenia (pp. 23-60). London: Routledge.
- Brown, W.A., & Herz, L.R. (1989). Response to neuroleptic drugs as a device for classifying schizophrenia. Schizophrenia Bulletin, 15, 123-128.
- Cornblatt, B.A., Lencz, T. & Kane, J.M. (2001). Treatment of the schizophrenia prodrome: Is it presently ethical? Schizophrenia Research, 51, 31-38.
- Day, J., Kinderman, P. & Bentall, R.P. (1997). Discordant views of neuroleptic side effects: A potential source of conflict between patients and professionals. Acta Psychiatrica Scandinavica, 97, 93-97.
- Drake, R.J., Haley, C.J., Akhtar, S. & Lewis, S.W. (2000). Causes of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry, 177, 511-515.
- Geddes, J., Freemantle, N., Harrison, P. & Bebbington, P. (2000). Atypical antips ychotics in the treatment of schizophrenia: Systematic overview and metaregression analysis. British Medical Journal, 321, 1371-1376.
- Gillon, R. (1985). Philosophical Medical Ethics. London: Wiley.
- Jablensky, A. (1995). Schizophrenia: The epidemiological horizon. In S.R. Hirsch & D.R. Weinberger (Eds.), Schizophrenia (pp. 206-252). Oxford: Blackwell.
- Kinon, B.J., Kane, J.M., Johns, C., Perovich, R. Ismi, M., Koreen, A. & Weiden, P. (1993). Treatment of neuroleptic resistantrelapse. Psychopharmacological Bulletin, 29, 309-314.
- Le Fanu, J. (1999). The Rise and Fall of Modern Medicine. London: Fontana.
- Lewander, T. (1994). Neuroleptics and the neuroleptic-induced deficit syndrome. Acta Psychiatrica Scandinavica, 89, 8-13.
- McGorry, P.D., Yung, A. & Phillips, L. (2001). Ethics and early intervention in psychosis: Keeping up the pace and staying in step. Schizophrenia Research, 51, 17-29.
- Morrison, A.P., Bentall, R.P., French, P., Walford, L., Kilcommons, A., Knight, A., Kreutz, M. & Lewis, S.W. (in press). A randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high risk individuals: Study design and interim analysis of transition rate and psychological risk factors. British Journal of Psychiatry.
- Poulton, R., Caspi, A., Moffitt, T.E., Cannon, M., Murray, R. & Harrington, H. (2000). Children's self-reported psychotic symptoms and adult schizophremform disorder: A 15-year longitudinal study. Archives of General Psychiatry, 57, 1053-1058.
- Romme, M. & Escher, A. (1996). Empowering people who hear voices. In G. Haddock & P.D. Slade (Eds.), Cognitive Behavioural Interventions with Psychotic Disorders (pp. 137-150). London: Routledge.
- Rosen, J.L., Woods, S.W., Miller, T.J. & McGlashan, T.H. (2002). Prospective observations of emerging psychosis. Journal of Nervous and Mental Disease, 190, 133-141.
- Smart, J.C.C. & Williams, B. (1973). Utilitarianism: For and against. Cambridge: Cambridge University Press.
- Tien, A. Y. (1991). Distribution of hallucinations in the population. Social Psychiatry and Psychiatrie Epidemiology, 26, 287-292.
- van Os, J., Hanssen, M., Bijl, R.V. & Ravelli, A. (2000). Strauss (1969) revisited: A psychosis continuum in the normal population? Schizophrenia Research, 45, 11-20.
- Verdoux, H., Maurice-Tison, S., Gay, B., Van Os, J., Salamon, R. & Bourgeois, M.L. (1998). A survey of delusional ideation in primary-care patients. Psychological Medicine, 28, 127-134.
- Warner, R. (1985). Recovery from Schizophrenia: Psychiatry and Political Economy. New York: Routledge & Kegan Paul.
- Wyatt, R.J. (1995). Early intervention in schizophrenia: Can the course of illness be altered? Biological Psychiatry, 38, 1-3.
- Yung, A.R., Philips, L.J., Mcgorry, P.D., McFarlane, C.A., Francey, S., Patton, G.C. & Jackson, H.J. (1998). The prediction of psychosis: A step towards indicated prevention of schizophrenia? British Journal of Psychiatry, 172 (Supplement), 14-20.
More harm than good: The case against using antipsychotic drugs to prevent severe mental illness
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.